ES2492681T3 - Método cromatográfico para purificar proteínas que contienen FC - Google Patents

Método cromatográfico para purificar proteínas que contienen FC Download PDF

Info

Publication number
ES2492681T3
ES2492681T3 ES11700457.2T ES11700457T ES2492681T3 ES 2492681 T3 ES2492681 T3 ES 2492681T3 ES 11700457 T ES11700457 T ES 11700457T ES 2492681 T3 ES2492681 T3 ES 2492681T3
Authority
ES
Spain
Prior art keywords
protein
concentration
sought
mobile phase
stationary phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11700457.2T
Other languages
English (en)
Inventor
Christian Eckermann
Dorothee Ambrosius
Franz Nothelfer
Thomas Rathjen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2492681T3 publication Critical patent/ES2492681T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Método para disminuir las impurezas de una composición que contiene una proteína con el dominio Fc de una inmunoglobulina (proteína buscada) mediante una cromatografía de proteína A que consta de las siguientes etapas: a) uso de una fase móvil que contiene la proteína buscada sobre una fase estacionaria que lleva la proteína A, en unas condiciones en que la proteína buscada se fija a la fase estacionaria; b) uso de un tampón de lavado con un pH comprendido entre 5 y 8 como fase móvil, que lleva como aditivos i) arginina a una concentración de 0,1 - 1 mol/l, ii) cloruro sódico a una concentración de 0,2 hasta 2 mol/l, iii) un alcohol elegido del grupo formado por isopropanol, n-propanol y etanol a una concentración del 5 - 30% (p/v) y iv) polivinilpirrolidona o un detergente a una concentración del 0,05 - 2% (p/v); c) uso de un tampón de elución como fase móvil, en unas condiciones en que la proteína buscada es eluida de la fase estacionaria.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6

Claims (1)

  1. imagen1
ES11700457.2T 2010-01-22 2011-01-21 Método cromatográfico para purificar proteínas que contienen FC Active ES2492681T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10151416 2010-01-22
EP10151416 2010-01-22
EP10171975 2010-08-05
EP10171975 2010-08-05
PCT/EP2011/050817 WO2011089212A1 (de) 2010-01-22 2011-01-21 Chromatographisches verfahren zur aufreinigung von fc enthaltenden proteinen

Publications (1)

Publication Number Publication Date
ES2492681T3 true ES2492681T3 (es) 2014-09-10

Family

ID=43598239

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11700457.2T Active ES2492681T3 (es) 2010-01-22 2011-01-21 Método cromatográfico para purificar proteínas que contienen FC

Country Status (11)

Country Link
US (1) US9284347B2 (es)
EP (1) EP2526114B1 (es)
JP (1) JP5567691B2 (es)
KR (1) KR101753569B1 (es)
CN (1) CN102712673B (es)
AU (1) AU2011208659B2 (es)
CA (1) CA2784959C (es)
DK (1) DK2526114T3 (es)
ES (1) ES2492681T3 (es)
SG (1) SG182553A1 (es)
WO (1) WO2011089212A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2560738B8 (en) * 2010-04-23 2019-09-25 Serum Institute of India Private Limited Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
AU2012264626B2 (en) * 2011-06-01 2015-11-05 Novartis Ag Wash solution and method for affinity chromatography
MX368142B (es) 2013-04-30 2019-09-20 Intas Pharmaceuticals Ltd Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
CN106536565A (zh) * 2014-06-13 2017-03-22 鲁宾有限公司 一种用于纯化TNFR‑Fc融合蛋白的方法
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
BR112017014224A2 (pt) 2014-12-31 2018-03-06 Lg Chem, Ltd. método para a preparação de proteína de fusão fc-tnfr que contém teor alvo de impurezas
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
CN109311948B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 清洁和/或消毒分离基质的方法
EP3455240B1 (en) 2016-05-11 2025-01-01 Cytiva BioProcess R&D AB Method of storing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
US11618769B2 (en) 2017-11-14 2023-04-04 Bio-Sourcing S.A. Antibody purification
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
CN113166200B (zh) * 2018-12-21 2024-03-01 上海药明生物技术有限公司 一种提高蛋白a层析法去除聚集体的方法
CN111333776B (zh) * 2020-03-20 2021-11-09 暨南大学 一种氮杂环类有机聚合物整体材料及制备与应用
WO2024017826A2 (en) * 2022-07-19 2024-01-25 Glaxosmithkline Intellectual Property Development Limited Methods for purifying recombinant polypeptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874218A (en) * 1990-06-11 1999-02-23 Nexstar Pharmaceuticals, Inc. Method for detecting a target compound in a substance using a nucleic acid ligand
US5585246A (en) * 1993-02-17 1996-12-17 Biometric Imaging, Inc. Method for preparing a sample in a scan capillary for immunofluorescent interrogation
AU2003210802B2 (en) * 2002-02-05 2009-09-10 Genentech Inc. Protein purification
US8084032B2 (en) * 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
US20070172846A1 (en) * 2005-11-12 2007-07-26 Introgen Therapeutics, Inc. Methods for the Production and Purification of Adenoviral Vectors
EP1994054A4 (en) 2006-01-06 2012-11-07 Amgen Inc METHODS AND SYSTEMS FOR ISOLATING TARGET MOLECULES OF COMPLEX COLUMN CHROMATOGRAPHY SOLUTIONS USING ELEMENTS CONTAINING ORGANIC SOLVENTS
WO2007109163A2 (en) * 2006-03-16 2007-09-27 Amgen Inc Wash buffer and method of using
US7714111B2 (en) * 2006-09-08 2010-05-11 Wyeth Llc Arginine derivative wash in protein purification using affinity chromatography
RU2011137030A (ru) * 2009-03-11 2013-04-20 УАЙТ ЭлЭлСи Способы очистки малых модулярных иммунофармацевтических белков
ES2982297T3 (es) * 2009-12-18 2024-10-15 Novartis Ag Método de cromatografía de afinidad

Also Published As

Publication number Publication date
CN102712673A (zh) 2012-10-03
US20130197197A1 (en) 2013-08-01
CA2784959C (en) 2018-06-26
AU2011208659A1 (en) 2012-07-19
HK1174044A1 (en) 2013-05-31
CN102712673B (zh) 2014-04-30
EP2526114A1 (de) 2012-11-28
DK2526114T3 (da) 2014-09-29
JP2013517318A (ja) 2013-05-16
KR20120118013A (ko) 2012-10-25
EP2526114B1 (de) 2014-06-18
AU2011208659B2 (en) 2015-05-28
KR101753569B1 (ko) 2017-07-04
US9284347B2 (en) 2016-03-15
CA2784959A1 (en) 2011-07-28
JP5567691B2 (ja) 2014-08-06
SG182553A1 (en) 2012-08-30
WO2011089212A1 (de) 2011-07-28

Similar Documents

Publication Publication Date Title
ES2492681T3 (es) Método cromatográfico para purificar proteínas que contienen FC
AR062570A1 (es) Proceso para la purificacion de las proteinas que contienen fc
AR069097A1 (es) Purificacion de anticuerpos por cromatografia de intercambio cationico
ES2500066T3 (es) Anticuerpos frente a ferroportina y métodos de uso
CL2012001966A1 (es) Formulación farmacéutica que comprende entre 100-150 mg/ml de un anticuerpo que se une específicamente al receptor a de il-17 humana, una solución acuosa de un buffer 5-30 mm de ácido glutámico ph 4,5-5,2, prolina 2-4% p/v y polisorbato-20 0,005-0,02% p/v; envase farmacéutico y kit que comprende dicha formulación; y su uso para tratar psoriasis.
RU2012130151A (ru) Промывочный раствор и способ промывки для аффинной хроматографии
MX395730B (es) Uso de lavados alcalinos durante la cromatografia para remover impurezas.
EA201290076A1 (ru) Специфичный сорбент для связывания белков и пептидов и способ выделения с его использованием
ES2585580T3 (es) Péptidos novedosos antienvejecimiento y composición cosmética y/o farmacéutica que los contiene
BRPI0806737A8 (pt) uso de sistema de renomeação de registrador para encaminhar resultados intermediários entre instruções constituintes de uma instrução expandida
EA201592192A1 (ru) Способ очистки моноклональных антител
BR112015027812A2 (pt) processo contínuo de multietapa para purificação de anticorpos
MX392628B (es) Amortiguador de lavado de cromatografia de afinidad.
AR085138A1 (es) VARIANTES DE Fc Y METODOS PARA SU PRODUCCION
AR097791A1 (es) Formulaciones de anticuerpos anti-pdl1
CL2013002888A1 (es) Anticuerpo que se une peptido antigenico que se obtiene a partir de una proteina tau; composicion farmaceutica que comprende; uso para tratar trastorno o enfermedad neurodegenerativa;kit de ensayo, linea celular (div 2457-2011).
AR095432A1 (es) Proteínas de unión a antígeno
MX2019015304A (es) Amortiguador de lavado para cromatografia de intercambio cationico.
CR9576A (es) METODOS PARA PURIFICAR PROTEINAS QUE CONTIENE LA REGION Fc
CO6280567A2 (es) Establecimiento de un anticuerpo monoclonal para detector de proteinas pag en la circulacion
MX2018001536A (es) Metodo para la reduccion de proteinas de celulas hospederas en cromatografia de afinidad.
EP4389757A3 (en) Methods for purifying antibodies
ES2464777T3 (es) Método de producción de proteína TAT-HOXB4H recombinante para su utilización como estimulante de la hematopoyesis in vivo
AR103172A1 (es) Reducción selectiva de residuos de cisteina en anticuerpos il-17
CL2020000087A1 (es) Cromatografía.